Evonile Pharma Q2 FY27: First Results After Novartis Exit
Evonile Pharma, formerly Novartis India, posted Q2 FY27 revenue of ₹56.1 crore and an EBITDA loss of ₹31.8 crore as it builds its own field force.
CHRYSCAPITAL
Mankind Pharma Enters Bid for Healthium Medtech in Competitive Surgical Supplies Market
In a bid to expand its portfolio and venture into the lucrative surgical supplies market, Mankind Pharma has entered the […]
